Parliamentary Search

Written question asked by Lord Weir of Ballyholme (Democratic Unionist Party) on Wednesday, 24 June 2026, in the House of Lords. It was due for an answer on Wednesday, 8 July 2026. It was answered by Baroness Merron (Labour) on Monday, 6 July 2026 on behalf of the Department of Health and Social Care.

Clinical Trials

Question

To ask His Majesty's Government how many people were recruited into the National Institute for Health and Care Research supported phase 3 trials for (1) dementia, (2) cancer, (3) stroke, and (4) coronary heart disease, in 2025–26.

Answer

The UK Clinical Research Delivery key performance indicators (UKCRD KPI) report monitors the United Kingdom’s delivery of globally competitive clinical research.

The following table shows the number of participants recruited for phase 3 trials for dementia, cancer, stroke, and coronary heart disease:

Disease type

Number of participants recruited

Dementia

208

Cancer

4908

Stroke

1267

Coronary heart disease

1092


This data is an unpublished subset of statistics published under indicator 6 of the UKCRD KPI report, which measures the number of participants recruited to clinical studies. The information is taken from studies recorded on the National Institute for Health and Care Research (NIHR) Research Delivery Network’s (RDN) Central Portfolio Management System.

Studies are included where they recruited during the period between 1 April 2025 and 31 March 2026. The data was processed and assured by the NIHR RDN data and analytics and specialty teams using the same established checks applied to the data provided to the Department for publication in the UKCRD KPI report.

Secondary information

Type
Written question
Reference
HL1308
Session
2026-27
Subjects
Cancer Dementia Heart diseases Strokes Clinical trials
Contains statistics
Yes
Link
View this Written question on www.parliament.uk